Verdiperstat

( DrugBank: Verdiperstat / KEGG DRUG: Verdiperstat )

3 diseases

ID	Disease name (Link within this page)	Number of trials
2	Amyotrophic lateral sclerosis	1
17	Multiple system atrophy	7

ID	Disease name (Link within this page)	Number of trials
127	Frontotemporal lobar degeneration	1

2. Amyotrophic lateral sclerosis

Clinical trials : 645 / Drugs : 589 - (DrugBank : 163) / Drug target genes : 150 - Drug target pathways : 225

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04297683 (ClinicalTrials.gov)	July 14, 2020	3/3/2020	HEALEY ALS Platform Trial - Master Protocol	HEALEY ALS Platform Trial	Amyotrophic Lateral Sclerosis	Drug: Zilucoplan;Drug: Verdiperstat;Drug: CNM-Au8;Drug: Pridopidine;Drug: SLS-005 Trehalose	Merit E. Cudkowicz, MD	Massachusetts General Hospital	Recruiting	18 Years	N/A	All	800	Phase 2/Phase 3	United States

First Previous1Next Last

17. Multiple system atrophy

Clinical trials : 119 / Drugs : 138 - (DrugBank : 44) / Drug target genes : 59 - Drug target pathways : 111

trials per page:

Showing 1 to 7 of 7 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05086094 (ClinicalTrials.gov)	October 14, 2021	8/10/2021	Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)	Intermediate-Size Patient Population Expanded Access Protocol of Verdiperstatin Patients With Multip ...	Multiple System Atrophy (MSA)	Drug: BHV3241, verdiperstat	Biohaven Pharmaceuticals, Inc.	NULL	No longer available	N/A	N/A	All			United States
2	EUCTR2019-001100-38-IT (EUCTR)	19/02/2020	26/01/2021	A study to assess whether a drug called BHV-3241 works and is safe to use in people with Multiple Sy ...	Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safe ...	Multiple System Atrophy MedDRA version: 21.1;Level: PT;Classification code 10064060;Term: Multiple s ...	Product Name: BHV-3241 Product Code: [/] INN or Proposed INN: Verdiperstat	Biohaven Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	252	Phase 3	France;United States;Austria;Germany;United Kingdom;China;Italy
3	EUCTR2019-001100-38-DE (EUCTR)	07/01/2020	07/10/2019	A study to assess whether a drug called BHV-3241 works and is safe to use in people with Multiple Sy ...	Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safe ...	Multiple System Atrophy MedDRA version: 21.1;Level: PT;Classification code 10064060;Term: Multiple s ...	Product Name: BHV-3241 INN or Proposed INN: Verdiperstat	Biohaven Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	422	Phase 3	United States;France;Austria;Germany;United Kingdom;Italy;China
4	EUCTR2019-001100-38-AT (EUCTR)	20/12/2019	29/10/2019	A study to assess whether a drug called BHV-3241 works and is safe to use in people with Multiple Sy ...	Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safe ...	Multiple System Atrophy MedDRA version: 21.1;Level: PT;Classification code 10064060;Term: Multiple s ...	Product Name: BHV-3241 INN or Proposed INN: Verdiperstat	Biohaven Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	422	Phase 3	United States;France;Austria;Germany;United Kingdom;Italy;China
5	EUCTR2019-001100-38-FR (EUCTR)	13/12/2019	03/10/2019	A study to assess whether a drug called BHV-3241 works and is safe to use in people with Multiple Sy ...	Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safe ...	Multiple System Atrophy MedDRA version: 21.1;Level: PT;Classification code 10064060;Term: Multiple s ...	Product Name: BHV-3241 INN or Proposed INN: Verdiperstat	Biohaven Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	252	Phase 3	Austria;United States;Italy;United Kingdom;France;Germany
6	EUCTR2019-001100-38-GB (EUCTR)	06/12/2019	11/10/2019	A study to assess whether a drug called BHV-3241 works and is safe to use in people with Multiple Sy ...	Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safe ...	Multiple System Atrophy MedDRA version: 21.1;Level: PT;Classification code 10064060;Term: Multiple s ...	Product Name: BHV-3241 INN or Proposed INN: Verdiperstat	Biohaven Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	422	Phase 3	United States;France;Austria;Germany;Italy;United Kingdom
7	NCT03952806 (ClinicalTrials.gov)	July 29, 2019	15/5/2019	Study of BHV-3241 in Subjects With Multiple System Atrophy	A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Evaluate the Efficacy and S ...	Multiple System Atrophy	Drug: Verdiperstat;Drug: Placebo	Biohaven Pharmaceuticals, Inc.	NULL	Completed	40 Years	80 Years	All	336	Phase 3	United States;Austria;France;Germany;Italy;United Kingdom

First Previous1Next Last

127. Frontotemporal lobar degeneration

Clinical trials : 90 / Drugs : 87 - (DrugBank : 30) / Drug target genes : 39 - Drug target pathways : 88

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05184569 (ClinicalTrials.gov)	April 14, 2022	17/12/2021	Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology	Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, Pharm ...	Semantic Dementia	Drug: Verdiperstat	Peter Ljubenkov, MD	National Institutes of Health (NIH);Alzheimer's Association;National Institute on Aging (NIA)	Recruiting	18 Years	85 Years	All	64	Phase 1	United States

First Previous1Next Last